Who owns TELOMIR PHARMACEUTICALS INC?
- Ticker: TELO
- CUSIP Number: 87975f104
Tip: Access positions for across all investors
Analyze quarterly positions in Telomir Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telomir Pharmaceuticals stock
Who bought or sold TELOMIR PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $1.5M | 3% | Dec 2025 |
|
| Vanguard Capital Management | 995k | $1.3M | 100% | Mar 2026 |
|
| BlackRock | 289k | $376k | 1% | Mar 2026 |
|
| Geode Capital Management | 249k | $324k | 11% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 136k | $176k | 100% | Mar 2026 |
|
| Millennium Management | 129k | $168k | -23% | Mar 2026 |
|
| State Street Corporation | 59k | $78k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 52k | $67k | 0% | Mar 2026 |
|
| Suncoast Equity Management | 51k | $67k | 0% | Mar 2026 |
|
| Northern Trust | 42k | $56k | 0% | Dec 2025 |
|
| XTX Topco | 40k | $53k | 100% | Dec 2025 |
|
| Pensionmark Financial Group | 37k | $48k | 5% | Mar 2026 |
|
| Advisor Group Holdings | 34k | $45k | 38% | Dec 2025 |
|
| Resources Investment Advisors | 23k | $30k | 0% | Mar 2026 |
|
| Praetorian Wealth Management | 20k | $27k | 100% | Mar 2026 |
|
| Virtu Financial | 14k | $19k | 100% | Dec 2025 |
|
| Vestmark Advisory Solutions | 13k | $17k | 0% | Mar 2026 |
|
| Morton Capital Management | 13k | $17k | 0% | Mar 2026 |
|
| Hartland & Co | 13k | $16k | 0% | Mar 2026 |
|
| Kestra Private Wealth Services | 11k | $14k | 0% | Mar 2026 |
|
| Regions Bank | 11k | $14k | 0% | Mar 2026 |
|
| Goldman Sachs Group | 10k | $14k | 100% | Mar 2026 |
|
| UBS Group | 9.2k | $12k | -34% | Mar 2026 |
|
| Vanguard Global Advisers | 6.6k | $8.5k | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 600.00 | $798.000000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 206.00 | $268.006000 | 0% | Mar 2026 |
|
| SBI Securities | 4.00 | $5.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $3.000000 | 100% | Mar 2026 |
|
| Barclays | 2.00 | $3.000000 | 0% | Dec 2025 |
|
Who sold out of Telomir Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Raymond James Financial | Sep 2025 | 75k | $105k |
| Jane Street | Dec 2025 | 12k | $16k |
| Mariner Wealth Advisors | Dec 2025 | 12k | $16k |
| Qube Research & Technologies | Sep 2025 | 11k | $15k |
| Two Sigma Securities | Dec 2025 | 10k | $13k |
| IFP Advisors | Dec 2025 | 3.0k | $4.0k |
| Fortitude Family Office | Dec 2025 | 1.3k | $1.8k |
| Tower Research Capital | Sep 2025 | 1.3k | $1.7k |
| Royal Bank of Canada | Sep 2025 | 599.00 | $0 |
| EverSource Wealth Advisors | Dec 2025 | 379.00 | $503.994200 |
| CWM | Sep 2025 | 2.00 | $0 |